By CARINE LEE
Biosensors International Group Ltd on Wednesday posted a net profit for the third quarter ended Dec 31, of US$291.54 million, from gain on remeasurement of joint-venture company, and realisation of translation difference in investment of the JV.
Profit excluding exceptional items was US$22.87 million, a 42 per cent increase year-on-year from US$16.15 million.
Revenues for the quarter nearly doubled to US$84.75 million from US$42.59 million, on the back of a surge in licensing and royalties revenues.
Earnings per share before exceptional items was 1.63 US cents, up from 1.37 US cents a year ago.
Including exceptionals, EPS was 17.78 cents. A year ago, EPS with exceptionals was 1.22 cents.
Year-to-date net profit before exceptional items was US$71.33 million, up 76 per cent year-on-year from US$40.41 million.
Turnover for the nine months rose 82 per cent to US$203.98 million from US$112.1 million.
Year-to-date earnings per share before exceptionals was 5.03 cents, up from 3.33 cents a year ago.
Including exceptional items, EPS for the nine months ended Dec 31, was 23.39 cents. A year ago, EPS with exceptional items was 2.32 cents.
Did you invest in Econ Healthcare’s IPO? - When it comes to investing on SGX, I’m not a fan of companies who delist only to re-list again later. Which is why I avoid their IPO, and tell you guys I h...
4 hours ago